money centra- Top Knowledge

Twenty-three domestic enterprises in the field of solid-state battery manufacturing have received 73 rounds of financing. According to incomplete statistics, up to now, 23 domestic enterprises in the field of solid-state battery manufacturing (including solid-state batteries, solid-state electrolytes, cathode materials, etc.) have received 73 rounds of financing. It is estimated that the number and amount of financing projects in the solid-state battery industry chain in 2024 are expected to exceed 2023 and reach a new high. Specifically, Qingtao Energy received 10 rounds of financing, Beijing Weilan New Energy Technology Co., Ltd. received 8 rounds of financing, Xinjie Energy Technology (Jiangsu) Co., Ltd., Tailan New Energy and Shenzhen Suolide New Materials Technology Co., Ltd. received 7 rounds of financing, ranking high.The pharmacy chain WBA rose to 4%. It is reported that Sycamore Partners LP is arranging a debt financing plan for the acquisition of WBA. Sycamore has contacted lenders such as Bank of America and JPMorgan Chase.GBP/USD fell more than 0.50% in the day, and now it is reported at 1.2611.

Google spokesperson: Google intends to appeal the decision of the Turkish Competition Authority. Earlier, the Turkish antitrust agency fined Google $75 million for advertising technology investigation.WTI crude oil rose 1.5% in the day to 70.71 USD/barrel.Russian Foreign Ministry spokesman: Kiev tried to use the resolution of the International Atomic Energy Agency on nuclear power plants to divert the world's attention from the attack on the employees of the agency.

Laurent Vauquier, French conservative leader: We will wait for Prime Minister Bayrou's policy plan before deciding whether to join the government.The pharmacy chain WBA rose to 4%. It is reported that Sycamore Partners LP is arranging a debt financing plan for the acquisition of WBA. Sycamore has contacted lenders such as Bank of America and JPMorgan Chase.The latest research results support Harvard's discovery that Novo Nordisk diet drug Ozempic is related to rare visual loss, and the large-scale test results show that Novo Nordisk diet drug Ozempic is related to rare visual loss, which supports the research results given by Harvard University earlier this year. Obese patients who use Ozempic are more than twice as likely to be diagnosed with NAION. NAION occurs when the blood flow decreases and damages the optic nerve. The risk of eye conditions is still low; Patients should pay attention. Novo Nordisk Denmark's share price once fell more than 3.3%.